5月7日，证监会印发《推动公募基金高质量发展行动方案》（以下简称《行动方案》），新规锚定"基 民赚钱"，告别"规模至上"，吹响了公募基金行业进一步深化改革、推进高质量发展的"号角"。 《行动方案》发布后，公募基金行业反响热烈。业内人士表示，《行动方案》围绕完善行业考核评价制 度、全面强化长周期考核与激励约束机制等提出诸多措施，将有效引导行业更加注重长期投资价值的创 造，有利于强化基金公司与投资者利益绑定，为投资者提供长期稳健的投资回报。 考核模式将从"规模导向" 转向"回报导向" 国联基金产品开发负责人许超认为，新考核机制将彻底打破公募基金"旱涝保收"的旧有格局，成为行业 优胜劣汰的关键转折点。基金经理为保薪酬、谋发展，必须重视投资者体验，与投资者"同甘共苦"。在 此机制下，基金经理将更关注投资策略的可持续性，自觉规避"风格漂移"、过度投机等行为，让基金收 益更稳定、可预期，切实满足投资者长期财富增值需求，实现行业与投资者共赢，推动公募基金健康长 远发展。 《行动方案》提出，改革基金公司绩效考核机制，包括出台基金公司绩效考核管理规定，全面建立以基 金投资收益为核心的考核体系，适当降低规模排名、收入利润等经营性 ...

Core Viewpoint - The recent announcement by the People's Bank of China and other regulatory bodies indicates a significant policy shift aimed at stimulating the economy and capital markets, particularly through monetary policy and capital market reforms [1][2]. Monetary Policy - The central bank has implemented a comprehensive reduction in the reserve requirement ratio by 0.5%, releasing approximately 1 trillion yuan in long-term funds, while also lowering policy interest rates by 10 basis points to 1.4% [2][3]. - Structural monetary tools, including the reduction of rates for specific loans, are designed to enhance medium to long-term funding supply and stabilize liquidity expectations [2]. Capital Market Reforms - The China Securities Regulatory Commission (CSRC) is focusing on optimizing the systems for the Sci-Tech Innovation Board and the Growth Enterprise Market, promoting high-quality development of public funds, and enhancing the long-term mechanisms supporting capital markets [3]. - The CSRC's initiatives are expected to provide stability and support for the market, particularly in the context of the new "National Nine Articles" policy and the overlapping trends of significant investment [3]. Investment Opportunities - The expansion of insurance funds for long-term investments is set to increase, with an additional 60 billion yuan in pilot investment quotas being approved, which is expected to boost the proportion of medium to long-term capital in the A-share market [3]. - The A500 index is highlighted as a favorable investment option due to its balanced industry representation and focus on emerging sectors, aligning with current economic development trends [5][6]. Market Sentiment - The combination of liquidity injection and supportive government signals is anticipated to elevate stock prices, particularly benefiting high-leverage sectors such as real estate, finance, and manufacturing [4]. - The low interest rate environment is expected to reduce corporate borrowing costs, enhancing profit expectations and encouraging a shift of funds from safe-haven assets to riskier equities [4].

Core Viewpoint - The Chinese government is implementing measures to enhance the role of insurance funds as patient and long-term capital in the capital market, aiming to stabilize and invigorate the market through increased investment [2] Group 1: Measures to Support Capital Market - The first measure includes expanding the pilot scope for long-term investment by insurance funds, with an additional 600 billion yuan planned for approval to inject more capital into the market [2][4] - The second measure involves adjusting solvency regulation rules, reducing the risk factor for stock investments by 10% to encourage insurance companies to increase their market participation [5] - The third measure promotes a long-cycle assessment mechanism to foster a "long money, long investment" approach [2][6] Group 2: Expansion of Long-term Investment Pilot - The long-term investment pilot for insurance funds began in October 2023, with initial participants including China Life and New China Life, each contributing 250 million yuan to establish a 500 million yuan private equity fund [3] - By early 2025, the scale of the long-term investment pilot had expanded to 1.62 billion yuan, with plans to reach 2.34 billion yuan including the new 600 billion yuan approval [4][5] Group 3: Impact of Risk Factor Adjustment - The adjustment of the risk factor for stock investments is expected to release a minimum capital of 364 million yuan, potentially leading to an influx of 2 billion yuan into the A-share market [5] - The reduction in risk factors is anticipated to improve the investment conditions for insurance companies, allowing them to better align with long-term value investment principles [4][5] Group 4: Long-cycle Assessment Mechanism - The current short assessment cycles for insurance companies have been a barrier to increasing A-share investments, with most companies using annual assessments [6] - The introduction of long-cycle assessments aims to encourage insurance funds to focus on long-term value investments, thereby supporting the healthy development of the capital market [6][7]

一揽子金融政策有效提振市场情绪。 5月7日，央行、金融监管总局、证监会负责人介绍"一揽子金融政策支持稳市场稳预期"有关情况。 本次发布会出台了降准降息、结构性货币政策工具降价扩容、险资入市加码、公募费率改革等众多增量政策。 公募基金普遍认为，会议释放积极政策信号，有效提振市场情绪。 发布会超预期 此次发布会上，央行发布三类共10项货币政策，延续货币政策适度宽松基调，强化逆周期调节和支持实体经济 发展。 金融监管总局发布8项增量政策，覆盖房地产、资本市场、小微民营企业、外贸及科技创新等多个领域。 证监会强调以下举措：巩固市场回稳向好势头，支持汇金公司发挥好"平准基金"作用；服务新质生产力发展， 出台深化科创板、创业板改革措施，抓紧发布新修订的《上市公司重大资产重组管理办法》和相关监管指引， 发展科技创新债券；推动中长期资金入市，抓紧落实《推动公募基金高质量发展行动方案》。 "这一次'一揽子金融政策'对市场的影响更偏细水长流。"招商基金指出，虽然市场对本次发布会第一反应的超 预期是央行"双降"，但随着关税冲击的显现，真正能让经济和市场行稳致远的仍在于货币金融政策和财政政策 的协同，预计随着"一揽子金融政策"在今年 ...

Core Viewpoint - The cash dividend distribution among listed companies in Zhejiang has significantly increased in 2024, with a total cash dividend amount surpassing 100 billion yuan for the first time, reflecting improved business conditions and a proactive approach to shareholder returns [2][5]. Group 1: Cash Dividend Statistics - In 2024, 468 out of 602 listed companies in Zhejiang plan to implement cash dividends, representing 77.74% of the total, which is 8.53 percentage points higher than the national average [2]. - The total proposed cash dividend for 2024 is 101.07 billion yuan, marking a year-on-year increase of 2.84%, with an average dividend payout ratio of 43.35%, up by 1.75 percentage points from the previous year [2]. - Among the 541 companies eligible for dividends, 86.51% are planning to distribute dividends, with 183 companies proposing dividends exceeding 10 million yuan, a 10.24% increase from the previous year [2]. Group 2: Private Companies and Dividend Trends - Nearly 80% of private listed companies in Zhejiang intend to distribute dividends in 2024, exceeding the national average for private companies by 9.47 percentage points [3]. - The total dividend amount from private companies is close to 64 billion yuan, reflecting a year-on-year growth of 4.96%, with dividends accounting for 45.81% of net profits, an increase of 3.32 percentage points from the previous year [3]. Group 3: Dividend Stability and Policy Impact - The stability, sustainability, and predictability of dividends among Zhejiang-listed companies have improved, with 314 companies having distributed dividends for three consecutive years, and 96 companies for ten consecutive years [4]. - Regulatory policies have emphasized the importance of dividends, encouraging companies to adopt stable and predictable dividend policies, which enhances corporate governance and investor satisfaction [4][5]. - In 2024, companies in the region have also engaged in share buybacks totaling over 21 billion yuan, a 74.51% increase, and significant shareholder buybacks exceeding 6 billion yuan, up by 96.34% [4]. Group 4: Future Outlook - The willingness of Zhejiang-listed companies to distribute dividends is expected to strengthen further due to the ongoing effects of the new "National Nine Articles" policy, which aims to promote long-term investment and improve market conditions [5][6].

每经记者｜涂颖浩 每经编辑｜廖丹 5月7日，国新办举行新闻发布会，介绍"一揽子金融政策支持稳市场稳预期"有关情况。金融监管总局局 长李云泽表示，充分发挥保险资金作为耐心资本和长期资本的作用，加大入市稳市力度，下一步将推出 三条措施继续支持稳定和活跃资本市场。 一是进一步扩大保险资金长期投资的试点范围，近期拟再批复600亿元，为市场注入更多增量资金；二 是调整偿付能力监管规则，将股票投资的风险因子进一步调降10%，鼓励保险公司加大入市力度；三是 推动长周期的考核机制，促进"长钱长投"。 自2023年9月金融监管总局发布《关于优化保险公司偿付能力监管标准的通知》调整股票风险因子以 来，在持续低利率环境倒逼下，保险资金持续加大股票配置比例。据中泰证券测算，假设本次针对险资 持有的沪深300股票风险因子下调10%，在50%沪深300成分股配置假设下，考虑风险分散效应前静态释 放最低资本为364亿元，若如果全部增配沪深300，对应股市资金达1349亿元。 业内人士指出，三条措施有助于稳定资本市场，从保险公司的角度而言，加大对股票资产的配置并长期 持有，可以更好落实长期价值投资理念，并聚焦与长期负债的匹配，实现穿越周期的 ...

巴菲特的离任将标志着美国商业史上一个独特时代的结束。巴菲特在1965年接手伯克希尔·哈撒韦，当 时这只是一家濒临倒闭的纺织厂，股价不足20美元。而截至上周五，该公司A类股收于创纪录的 809,808.50美元，铸就了企业历史上最令人瞩目的长期业绩之一。 几十年来，人们不断猜测巴菲特离开之后的伯克希尔·哈撒韦会是什么样子。2003年，时年仅72岁的他 曾打趣说，如果自己"开始糊涂了"，全家人都得来劝他退位。二十多年后，这一时刻终于到来，不过并 非因为他"开始糊涂了"，而是出于远见和一贯的谦逊。 不可复制的组合 智通财经APP获悉，当地时间5月3日，一年一度的伯克希尔·哈撒韦(BRK.A.US)股东大会在小镇奥马哈 举行。"股神"巴菲特当天宣布，他计划在年底退休，并表示将向伯克希尔·哈撒韦公司董事会推荐非保 险业务副董事长格雷格·阿贝尔在年底接任首席执行官的职位，称他认为阿贝尔担任公司首席执行官的 时机已经成熟。 尽管巴菲特的接班人计划早已制定好，但巴菲特宣布计划于年底退休的声明让股东乃至部分董事会成员 都感到意外，且这一声明引发的震撼仍在引发广泛回响。有媒体称："(巴菲特)他的离开早已被认为是 不可避免的，但这 ...

市场的表层价格总是波动不定，有时甚至过度。他曾说："悲观是朋友，陶醉是敌人。"他认为， 只有当市场忽视本源价值时，投资良机才会到来。巴菲特曾在可口可乐、美国运通等股价处于低 值时集中投资，这些最终都成为了巨大资产。 选择能够持续实现高利润率的优质企业并长期持有，从而实现复利效应，使投资收益像滚雪球一 样不断增加。长期的价值投资正是巴菲特投资哲学的核心。 "不了解的事物就不投资"。他曾在2000年IT热潮中未予跟进，当时被认为"神通不再"，但后来IT泡 沫破裂，其独具慧眼再次获得认可。 巴菲特的长期投资取得了巨大成功，自身投资公司的股价在60年间增长至6万倍。正因为如此， 他树立了一个旨在实现健全且可持续发展的美国资本主义的范例。他通过自身实践，证明股票投 资不仅是短线交易工具，更是成为企业所有者、参与企业长期成长的手段。 巴菲特（REUTERS） 著名投资家、被称为"奥马哈的先知"的巴菲特宣布2025年年底将卸任投资公司伯克希尔·哈撒韦的 CEO。他既是美国繁荣的最大体现者，也曾在美国的危机时刻出手相救。他选择退休恰逢特朗普 第二次上台执政。这是否也预示着美国资本主义的某种变质？ 美国著名投资家沃伦·巴菲特于 ...

Group 1 - Warren Buffett acknowledged that Apple is his most profitable investment, expressing gratitude towards CEO Tim Cook for creating significant wealth for Berkshire Hathaway [1] - Buffett's previous skepticism towards technology stocks changed when he invested in Apple in 2016, breaking his long-standing investment rules and achieving substantial returns [2] - Berkshire Hathaway's investment in Apple started with $1 billion, and the company became a major shareholder, increasing its stake over the years [3] Group 2 - Despite the successful investment, Berkshire Hathaway began to gradually reduce its holdings in Apple starting from Q4 2023, decreasing from 905 million shares at the end of 2023 to 300 million shares by the end of 2024, a reduction of nearly two-thirds [3] - Apple remains the largest holding for Berkshire Hathaway, with its market value significantly exceeding that of the next largest holdings, American Express and Bank of America [3]

25Q1 基金医药持仓：企稳回升，创新药加仓较多 20250427 摘要 • 医药市场进入业绩披露期，创新药虽短期受情绪影响，但因其超额收益， 长期投资价值明确，调整提供入场机会，仍是最明确主线，同时关注骨科 等器械领域。 • 业绩优异的底部个股如甘李药业、三外三等展现增长潜力，投资策略除创 新药主线外，应关注业绩驱动型股票。 • 推荐组合包括康弘、一品红、人福医药、华康净化和宜和佳业，分别受益 于核心产品增长、痛风药潜力、管理层变动、新业务拓展和业绩亮眼。 • 康方生物基本面稳健，Semperit 股价下跌因市场预期过高，康方市场预 期相对合理，长期价值投资理念至关重要。 • 康方临床试验 HR 值为 0.77，PFS 已获批，OS 显示显著趋势，中位 OS 可能提升 5.5 个月，一线治疗 PFS 获益尤为重要。 • 康方国内临床试验样本量 400 例，海外预计 780 例，海外一线治疗 PFS 获益更易实现 OS 获益，Hamilton 7 研究成功率或上调。 • 2025 年关注海外临床研究结果，若与国内一致，有望获美国 FDA 批准， 将成股价催化剂，医药板块仍有加仓空间，主动基金超配创新药。 Q& ...